Kevin T. Nead, MD, MPhil
Department of Epidemiology, Division of Cancer Prevention and Population Sciences
Present Title & Affiliation
Primary Appointment
Member, Division of Cancer Prevention and Population Sciences, The University of Texas Graduate School of Biomedical Sciences, Houston, TX
Assistant Professor, Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX
Assistant Professor, Department of Breast Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Member, The University of Texas Graduate School of Biomedical Sciences, Houston, Texas
Assistant Professor, Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas
Assistant Professor, Department of Breast Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas
Education & Training
Degree-Granting Education
| 2014 | Stanford University School of Medicine, Stanford, California, US, MD |
| 2012 | University of Cambridge, Cambridge, GB, Epidemiology, MPhil (Masters) |
| 2008 | University of Florida, Gainesville, Florida, US, Zoology, BS |
Postgraduate Training
| 2015-2019 | Clinical Residency, Radiation Oncology, University of Pennsylvania Health System, Philadelphia, Pennsylvania |
| 2014-2015 | Clinical Internship, Internal Medicine, University of Pennsylvania Health System, Philadelphia, Pennsylvania |
Board Certifications
| 2021 | American Board of Radiology (Radiation Oncology) |
Experience & Service
Other Appointments/Responsibilities
Associate Fellow, Leonard Davis Institute of Health Economics, Philadelphia, PA, 2015 - 2019
Institutional Committee Activities
Member, Institutional Research Management Policy Guideline Committee, 2025 - Present
Co-Director, Seminar Series Committee, Department of Epidemiology, 2024 - Present
Member, Occupational Cancer Prevention Symposium Planning Committee, 2024 - Present
Member, Institute for Data Science in Oncology (IDSO) Internal Advisory Council (IAC), 2024 - Present
Member, MedTech Innovation Council, 2024 - Present
Senator (Elected), Faculty Senate, 2023 - Present
Member (Elected), Physicians Referral Service Clinical Revenue Cycle Committee, 2023 - Present
Member, Department of Health Services Research Faculty Search Committee, 2022 - Present
Member, Department of Epidemiology Faculty Search Committee, 2022 - Present
Chair, Translational Research Committee, Department of Breast Radiation Oncology, 2022 - Present
Voting Member, Appropriate Use Criteria Breast Committee, 2021 - 2024
Member, Division of Radiation Oncology Faculty Search Committee, 2021 - Present
Member, Academic Review Committee for the Division of Education & Training, 2020 - 2023
Director, Seminar Series Committee, Department of Epidemiology, 2020 - 2024
Honors & Awards
| 2025 | Leading Mentor in Cancer Prevention, Division of Cancer Prevention and Population Science, Nominated, The University of Texas MD Anderson Cancer Center |
| 2024 | ASTRO Annual Meeting Travel Award, Biology, ASTRO |
| 2024 | JACC CardioOnc’s Young Author Achievement Award (Mentor), American College of Cardiology |
| 2023 | Leading Mentor in Cancer Prevention, Division of Cancer Prevention and Population Science, The University of Texas MD Anderson Cancer Center |
| 2022 | Educator of the Year, Association of Residents in Radiation Oncology (ARRO) |
| 2018 | Conquer Cancer Foundation of ASCO Merit Award, The American Society of Clinical Oncology Foundation |
| 2018 | Charles J. Epstein Trainee Award for Excellence in Human Genetics Research - Finalist, American Society of Human Genetics |
| 2016 | B. Leonard Holman Research Pathway, The American Board of Radiology |
| 2013 | Travel Grant, Society for Vascular Medicine |
| 2013 | Kaiser Permanente of Northern California Medical Student Scholarship, Kaiser Permanente |
| 2013 | MacKenzie Foundation Scholarship, MacKenzie Foundation |
| 2013 | Young Investigator Award - Finalist, American College of Cardiology |
| 2012 | 1st in Class - GlaxoSmithKline Award, University of Cambridge |
| 2012 | American Heart Association Student Scholarship in Cardiovascular Disease and Stroke, American Heart Association |
| 2012 | Distinction in the MPhil thesis, examinations, and degree, University of Cambridge |
| 2012 | Scholar-in-Training Award, American Association for Cancer Research |
| 2011 | Gates-Cambridge Scholarship, Gates-Cambridge |
| 2010 - 2012 | Medical Scholars Research Fellowship, Stanford University |
| 2010 | Medical Student Research Fellowship, American Heart Association |
| 2008 | Postgraduate Scholarship, National Collegiate Athletic Association (NCAA) |
| 2008 | Summa Cum Laude, University of Florida |
| 2008 | United States Olympic Swimming Trials Qualifier, United States Olympics |
| 2008 | Academic-All American; First Team, Division I, National Collegiate Athletic Association (NCAA) |
| 2008 | Phi Beta Kappa, University of Florida |
| 2007 | Howard Hughes Medical Institute Undergraduate Research Fellowship, University of Florida |
| 2005 | United States Swimming National Championship Finalist, USA Swimming |
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Schalck A, Tran T, Li J, Sei E, Bai S, Hu M, Lin J, Bright SJ, Reddick S, Yang F, Batra H, Contreras A, Raso MG, Stauder MC, Hoffman KE, Reddy JP, Nead KT, Smith BD, Sawakuchi GO, Woodward WA, Watowich SS, Litton JK, Bedrosian I, Mittendorf EA, Le-Petross H, Navin NE, Shaitelman SF. The impact of breast radiotherapy on the tumor genome and immune ecosystem. Cell Rep 44(5):115703, 2025. e-Pub 2025. PMID: 40378044.
- Ugalde-Morales E, Wilf R, Pluta J, Ploner A, Fan M, Damra M, Aben KK, Anson-Cartwright L, Chen C, Cortessis VK, Daneshmand S, Ferlin A, Gamulin M, Gietema JA, Gonzalez-Niera A, Grotmol T, Hamilton RJ, Harland M, Haugen TB, Hauser R, Hildebrandt MAT, Karlsson R, Kiemeney LA, Kim J, Lessel D, Lothe RA, Loveday C, Chanock SJ, McGlynn KA, Meijer C, Nead KT, Nsengimana J, Popovic M, Rafnar T, Richiardi L, Rocca MS, Schwartz SM, Skotheim RI, Stefansson K, Stewart DR, Turnbull C, Vaughn DJ, Winge SB, Zheng T, Monteiro AN, Almstrup K, Kanetsky PA, Nathanson KL, Wiklund F. Identification of genes associated with testicular germ cell tumor susceptibility through a transcriptome-wide association study. Am J Hum Genet 112(3):630-643, 2025. e-Pub 2025. PMID: 39999848.
- Casso-Chapa B, Vazquez Gonzalez NA, Le NT, Palaskas NL, Nead KT, Eutsey LP, Samanthapudi VSK, Osborn AM, Lee J, Mejia G, Hoang O, Lin SH, Deswal A, Herrmann J, Wang G, Kirkland JL, Krishnan S, Wehrens XHT, Chini EN, Yusuf SW, Iliescu CA, Jain A, Burks JK, Seeley E, Lorenzi PL, Chau KM, Ostos Mendoza KC, Grumbach IM, Brookes PS, Hanssen NMJ, de Winther MPJ, Yvan-Charvet L, Kotla S, Schadler K, Abe JI. Reevaluating Anti-Inflammatory Therapy: Targeting Senescence to Balance Anti-Cancer Efficacy and Vascular Disease. Arterioscler Thromb Vasc Biol 45(3):372-385, 2025. e-Pub 2025. PMID: 39817327.
- Angelov I, Haas AM, Brock E, Luo L, Zhao J, Smith BD, Giordano SH, Leeper NJ, Nead KT. Cardiovascular Disease and Breast Cancer Stage at Diagnosis. JAMA Netw Open 8(1):e2452890, 2025. e-Pub 2025. PMID: 39745699.
- Navsaria LJ, Haas AM, Corredor JL, Arun BK, Giordano SH, Nead KT, Wehner MR. Skin cancer risk in patients with BRCA mutations. JAAD Int 17:175-177, 2024. e-Pub 2024. PMID: 39525845.
- So A, Yi M, Simons JM, Kuerer HM, Caudle A, DeSnyder SM, Bedrosian I, Nead KT, Chavez-MacGregor M, Teshome M, Hunt KK. Significance of Residual Nodal Disease in Clinically Node-Negative Breast Cancer After Neoadjuvant Chemotherapy. Ann Surg Oncol 32(2):922-930, 2024. e-Pub 2024. PMID: 39441324.
- Gajagowni S, Hopkins S, Qadeer Y, Virani SS, Verdonschot JAJ, Coombs CC, Amos CI, Nead KT, Jaiswal S, Krittanawong C. Clonal hematopoiesis of indeterminate potential and cardiovascular disease: Pathogenesis, clinical presentation, and future directions. Prog Cardiovasc Dis 86:79-85, 2024. e-Pub 2024. PMID: 39278303.
- Nead KT, Kim T, Joo L, McDowell T, Wong J, Chan IC, Brock E, Zhao J, Xu T, Tang C, Lee CL, Abe JI, Bolton KL, Liao Z, Scheet P, Lin SH. Impact of Cancer Therapy on Clonal Hematopoiesis Mutations and Subsequent Clinical Outcomes. Blood Adv 8(19):5215-5224, 2024. e-Pub 2024. PMID: 38830141.
- Luo L, Haas AM, Bell CF, Baylis RA, Adkar SS, Fu C, Angelov I, Giordano SH, Klarin D, Leeper NJ, Nead KT. Cancer Incidence After Diagnosis of Abdominal Aortic Aneurysm. Arterioscler Thromb Vasc Biol 44(7):1694-1701, 2024. e-Pub 2024. PMID: 38779853.
- Cohen OG, Taylor M, Mohr C, Nead KT, Hinkston CL, Giordano SH, Langan SM, Margolis DJ, Wehner MR. Antihypertensive Medications and Risk of Melanoma and Keratinocyte Carcinomas: A Systematic Review and Meta-Analysis. JID Innov 4(3):100272, 2024. e-Pub 2024. PMID: 38736521.
- Miller ZA, Mueller A, Kim T, Jolivert JF, Ma RZ, Muthuswami S, Park A, McMahon DB, Nead KT, Carey RM, Lee RJ. Lidocaine induces apoptosis in head and neck squamous cell carcinoma through activation of bitter taste receptor T2R14. Cell Rep 42(12):113437, 2023. e-Pub 2023. PMID: 37995679.
- Nead KT, Hinkston CL, Wehner M. Cautions When Using Race and Ethnicity in Administrative Claims Data Sets. JAMA Health Forum 3(7), 2022. e-Pub 2022. PMID: 36218996.
- Stjepanovic N, Villacampa G, Nead KT, Torres-Esquius S, Melis GG, Nathanson KL, Teulé A, Brunet J, y Cajal TR, Llort G, Dienstmann R, Rue M, Domchek SM, Balmaña J. Association of premenopausal risk-reducing salpingo-oophorectomy with breast cancer risk in BRCA1/2 mutation carriers. European Journal of Cancer 132:53-60, 2020. e-Pub 2020. PMID: 32325420.
Invited Articles
- Wehner M, Nead KT. Can Google help us fight cancer?. The lancet oncology 19(7):867, 2018. e-Pub 2018. PMID: 30084368.
Editorials
- Neth BJ, Wefel JS, Nead KT. Cognitive outcomes in prostate cancer treatment: insights from the ODENZA trial and future considerations. Transl Androl Urol 14(4):864-867, 2025. PMID: 40376525.
Book Chapters
- Fedirko V, Nead KT, Daniel C, Scheet P. Cancer Epidemiology. In: Holland‐Frei Cancer Medicine. John Wiley & Sons, Inc, 2022.
Letters to the Editor
- Nead KT, Swisher-McClure S, Shah NH. Androgen Deprivation Therapy and Subsequent Dementia-Reply. JAMA Oncol 3: 1001-1002, 2017.
- Nead KT, Gaskin G, Chester C, Swisher-McClure S, Dudley J, Leeper NJ, Shah NH. Reply to R.L. Bowen et al, M. Froehner et al, J.L. Leow et al, and C. Brady et al. Journal of Clinical Oncology 34: 2804-2805, 2016.
Selected Presentations & Talks
Local Presentations
- 2025. CPRTP Cancer Prevention in Action Education Panel. Invited. Cancer Prevention Research Training Program. Houston, Texas, US.
- 2025. Clonal hematopoiesis and cancer therapy. Invited. Biology of Hematologic Malignancies Seminar Series. Houston, TX, US.
- 2025. Screening/surveillance techniques. Invited. Occupational Flight Exposure and Cancer Risk Symposium, US.
- 2024. Impact of Cancer Therapy on Clonal Hematopoiesis Mutations and Subsequent Clinical Outcomes. Invited. Cancer Center Support Grant Cancer Prevention Program Meeting. Houston, Texas, US.
- 2024. Impact of Cancer Therapy on Clonal Hematopoiesis Mutations and Subsequent Clinical Outcomes. Invited. Research Town Hall. Houston, Texas, US.
- 2022. Hormone Therapy and Adverse Neurocognitive Outcomes. Invited. Division of Cancer Prevention and Population Sciences Grand Rounds, US.
- 2019. Etiology to outcomes: Integration of cancer genetics and the electronic health record. Invited. Department of Radiation Oncology Seminar Series. Philadelphia, PA, US.
National Presentations
- 2025. Cardiovascular disease and cancer risk. Invited. Northwestern Vascular Symposium. Chicago, Illinois, US.
- 2024. The impact of cardiovascular disease on breast cancer stage at diagnosis. Poster. 2024 San Antonio Breast Cancer Symposium. San Antonio, Texas, US.
- 2024. Cancer Incidence After Diagnosis of Abdominal Aortic Aneurysm. Invited. Chicago-Wide Vascular Surgery Journal Club. Chicago, IL, US.
- 2024. Impact of Cancer Therapy on Clonal Hematopoiesis Mutations and Subsequent Clinical Outcomes. Conference. ASTRO 66th Annual Meeting. Washington, DC, US.
- 2024. Cancer, Aneurysms, & Atherosclerosis - Emerging Epidemiological Links. Invited. Vascular Scientific Sessions. Houston, TX, US.
- 2019. Etiology to outcomes: Integration of cancer genetics and the electronic health record. Invited. Department of Epidemiology Seminar Series. Houston, TX, US.
- 2019. Etiology to outcomes: Integration of cancer genetics and the electronic health record. Invited. Etiology to outcomes: Integration of cancer genetics and the electronic health record. Houston, TX, US.
- 2018. Etiology to outcomes: Integration of cancer genetics and the electronic health record. Invited. Etiology to outcomes: Integration of cancer genetics and the electronic health record. Nashville, TN, US.
- 2018. Diagnostic radiation and testicular germ cell tumor risk. Poster. American Society for Clinical Oncology. San Francisco, CA, US.
- 2018. Risk of pediatric malignancy in families known to carry BRCA1/2 mutations. Poster. American Society of Clinical Oncology. Chicago, IL, US.
- 2018. Association of clonal hematopoiesis mutations with adverse outcomes in a diverse hospital-based biobank. Conference. American Society of Human Genetics. San Diego, CA, US.
- 2017. Association of androgen deprivation therapy in the treatment of prostate cancer and depression: A systematic review and meta-analysis. Poster. American Society for Radiation Oncology. San Diego, CA, US.
- 2017. Influence of age on androgen deprivation therapy-associated Alzheimer's disease. Poster. American Association for Cancer Research. New Orleans, LA, US.
- 2017. Androgen deprivation therapy in the treatment of prostate cancer and dementia risk: A systematic review and meta-analysis. Poster. American Society of Clinical Oncology. Chicago, IL, US.
- 2016. Androgen deprivation therapy and risk of dementia. Conference. American Society for Radiation Oncology. Boston, MA, US.
- 2015. Text-mining methods applied to clinical records support an association between androgen deprivation therapy and subsequent cardiometabolic disease. Poster. American Association for Cancer Research. Philadelphia, PA, US.
- 2013. An alternative ankle-brachial index method identifies individuals at high-risk for cardiovascular mortality that are currently overlooked. Conference. American College of Cardiology. San Francisco, CA, US.
- 2012. Evidence of a causal association between fasting insulin concentrations and endometrial cancer: A Mendelian randomization analysis. Poster. American Association for Cancer Research. Anaheim, CA, US.
- 2012. The walking impairment questionnaire predicts total and cardiovascular mortality independent of peripheral artery disease status. Conference. American Heart Association. Los Angeles, CA, US.
Grant & Contract Support
| Date: | 2025 - 2027 |
| Title: | The role of cancer in cardiovascular disease |
| Funding Source: | NIH/NHLBI |
| Role: | Co-I |
| ID: | R35HL176060 |
| Date: | 2025 - 2028 |
| Title: | Clonal hematopoiesis and toxicity from radiation therapy |
| Funding Source: | CPRIT |
| Role: | PI |
| ID: | RP250062 |
| Date: | 2024 - 2025 |
| Title: | Characterization and Prediction of Second-Generation Anti-Androgen Associated Neurotoxicity in Patients with Prostate Cancer |
| Funding Source: | Cancer Neuroscience Program, MD Anderson |
| Role: | PI |
| ID: | CNP129405 |
| Date: | 2021 - 2026 |
| Title: | Impact of clonal hematopoiesis mutations on toxicity and outcomes following oncologic therapy |
| Funding Source: | NIH/NCI |
| Role: | PI |
| ID: | K08CA263313 |
| Date: | 2021 - 2024 |
| Title: | Risk Factors and Mechanisms of Radiation-Induced Cardiovascular Disease |
| Funding Source: | Multidisciplinary Research Program (MRP) |
| Role: | Core Leader |
| ID: | RCTS#00059910 |
| Date: | 2020 - 2025 |
| Title: | Causes and consequences of clonal hematopoiesis mutations |
| Funding Source: | NIH/NCI (Loan Repayment Program) |
| Role: | PI |
| ID: | L30CA253796 |
| Date: | 2020 - 2022 |
| Title: | Defining acquired mutations in healthy breast tissue and their association with breast cancer risk factors and breast cancer risk |
| Funding Source: | Duncan Family Institute |
| Role: | PI |
| Date: | 2020 - 2021 |
| Title: | Clonal hematopoiesis among individuals with non-hematologic cancer: association with comorbid disease and treatment toxicity |
| Funding Source: | Conquer Cancer Foundation of ASCO |
| Role: | PI |
| Date: | 2019 - 2022 |
| Title: | Science and Technology Acquisition and Retention Program (STARs) |
| Funding Source: | University of Texas (UT) |
| Role: | PI |
| Date: | 2019 - 2025 |
| Title: | Recruitment of First-Time, Tenure-Track Faculty Members |
| Funding Source: | CPRIT |
| Role: | PI |
| ID: | RR190077 |
| Date: | 2019 - 2019 |
| Title: | Clonal hematopoiesis among individuals with non-hematologic cancer: association with comorbid disease and treatment toxicity |
| Funding Source: | Marlene Shlomchik Fellowship in Cancer Research; Abramson Cancer Center, University of Pennsylvania Perelman School of Medicine |
| Role: | PI |
| Date: | 2018 - 2019 |
| Title: | Risk of cancer in children among families known to carry BRCA1/2 mutations |
| Funding Source: | The Gerber Foundation |
| Role: | PI |
Patient Reviews
CV information above last modified July 02, 2025